KalVista Pharmaceuticals Announces Changes to Board of Directors
yahoo.com
news
2022-05-27 10:45:00

– Patrick A. Treanor Appointed Effective Immediately –

– Dan Soland Resigns in Planned Transition –

CAMBRIDGE, Mass. & SALISBURY, England, May 27, 2022--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that Patrick A. Treanor has been appointed and Dan Soland is resigning from the Company's Board of Directors. Both changes are part of a planned transition and are effective immediately.
